Patients with metastatic melanoma who do not respond well to other therapies may be candidates for treatment with aldesleukin.

It is important to get treatment for malignant melanoma. Without treatment, the cancer will go deeper into the skin and spread throughout the body, eventually leading to death.

Malignant melanoma may develop anywhere on the body.

Though radiation therapy has a minimal role in the primary treatment of malignant melanoma, for patients who have metastatic disease, radiation may be helpful.

Some patients, such as those with IIb or stage III melanoma, are at high risk for the development of recurrence after treatment.